Pacific Biosciences of California

Pacific Biosciences of California

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$40,564
$39,007
$37,178
$44,645
Gross Profit
13,470
12,638
12,841
16,748
EBITDA
-35,520
-38,052
-5,766
-33,780
EBIT
-35,520
-42,573
-9,831
-38,429
Net Income
-37,846
-44,741
-8,275
-40,371
Net Change In Cash
40,564
39,007
37,178
44,645
Free Cash Flow
-38,593
-81,829
-47,734
-19,930
Cash
55,907
61,003
56,293
63,707
Basic Shares
311,247
310,655
305,819
301,907

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$160,005
$154,014
$200,521
$128,304
Gross Profit
50,674
37,282
52,780
49,035
EBITDA
-152,692
-242,772
-271,125
-282,240
EBIT
-539,104
-296,123
-303,816
-299,558
Net Income
-546,376
-309,851
-306,735
-314,248
Net Change In Cash
160,005
154,014
200,521
128,304
Free Cash Flow
-113,923
-212,246
-275,391
-280,140
Cash
63,707
55,370
179,911
325,089
Basic Shares
299,959
288,366
253,629
224,550

Earnings Calls

QuarterEPS
2026-09-30
-$0.11
2026-06-30
-$0.14
2026-03-31
-$0.12
2025-12-31
-$0.12